FDA clears Novo Nordisk's weight loss drug Saxenda
The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss.
Dec 23, 2014
0
1
The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss.
Dec 23, 2014
0
1
Despite showing interest in web or mobile apps to help manage their Type 2 diabetes, only a small number of older adults actually use them, says a new study from the University of Waterloo. Approximately 2.2 million Canadians ...
Dec 19, 2014
0
0
A study of more than 80,000 women has uncovered different risks of developing type 2 diabetes associated with different blood groups, with the biggest difference a 35% increased risk of type 2 diabetes found in those with ...
Dec 18, 2014
0
0
While people of Mexican ancestry are nearly twice as likely to develop Type 2 diabetes as people of European heritage, the majority of research in this area has focused on those of European origin.
Dec 17, 2014
0
0
In a report published today in the journal of Diabetes, Obesity and Metabolism, researchers from Cardiff University were also able to show a correlation between patients treated with a higher dosage of insulin and a raised ...
Dec 9, 2014
0
0
A new substance that unifies the action profiles of three gastrointestinal hormones lowers the blood sugar level and reduces body fat considerably beyond existing drugs. With the discovery and validation of such novel molecules, ...
Dec 8, 2014
1
1
The risk of developing type 2 diabetes, obesity, and cardiovascular disease is affected by exposures in the uterus. Researchers at Lund University in Sweden are now calling for updated guidelines in light of research evidence ...
Dec 5, 2014
0
0
(HealthDay)—For men with type 2 diabetes, low serum testosterone seems to be implicated in adverse clinical outcomes, according to a review published online Nov. 3 in the Journal of Diabetes Investigation.
Dec 4, 2014
0
0
New research published in the December 2014 issue of the Journal of Leukocyte Biology, shows that a component found in in the plant, Glycyrrhiza uralensis, may inhibit the development of metabolic disorders by stopping the ...
Dec 1, 2014
0
1
Behavioural and drug interventions aiming to prevent people with prediabetes progressing to full blown type 2 diabetes are equally effective for both sexes at preventing progression and reducing weight, according to a new ...
Nov 28, 2014
0
0